Eastpro Technology Inc.

Eastpro Technology Inc. is a pharmaceutical company engaged in the development and manufacture of pharmaceutical chemicals and nutritional supplements. Founded in 2000, Eastpro Technology Inc. is a 50/50 joint venture of Huadong Pharmaceutical Group of China and Pronet Science Inc. of US with principle business place at Hangzhou, China. Huadong Pharmaceutical Group is a well-known company in the industry with the annual sales of $230 million in 2000. Pronet Science Inc was incorporited in 2000 by seasoned executives of 20 plus year experience in the US pharmaceutical industry. The business strategy of Eastpro is to manufacture products in China and export to overseas markets. To meet global GMP (good manufacturing practice) standards and regulatory requirements, the company has established a team of international professionals to strengthen quality and regulatory infrastructures. At present, the company offers a number of synthetic drugs, fermentation-derived medicines, biotech products, botanical extracts, pharmaceutical and chemical intermediates and nutritional supplements. Major products include antibiotics, anti-diabetics and statins. With a capable R&D team, Eastpro is able to timely develop new products needed by our customers. Our management team has extensive global experience. With timeliness, quality and efficiency as our guiding principles, we are confident that we can create value and offer competitiveness to our customers. Main products: 　　Rapmycin　　 Tacrolimus Acarbose　　 Cyclosporine 　　Cordyceps Sinensis Powder 　　　　　　Eflornithine HCL 　　Geldanamycin Raw Material Coenzyme Q10 Powder 　　Mupirocin and its relative derivatives　　　Corbrin capsules